Coupled with the lack of association with disease stage and other markers of disease burden, our findings suggest that circulating IL-6 may derive from sources other than the TME in the setting of HIV-DLBCL (possibly as a result of chronic immune stimulation consequent upon recurrent/chronic infection). This evidence concerns the gene IL6 and diffuse large B-cell lymphoma.